the evolving role of venetoclax in cll
Published 1 year ago • 797 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
2:08
the role of venetoclax in the treatment of cll
-
5:31
the role of venetoclax in older patients with aml
-
3:29
how the management of cll is evolving
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
-
2:18
first-line ibrutinib and venetoclax in cll
-
5:02
a retrospective study of venetoclax re-treatment in cll patients
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
12:05
venetoclax combinations, safety and efficacy
-
7:42
cll / sll leukemia basics
-
3:33
venetoclax (bcl 2 inhibitor)
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
4:38
venice i: venetoclax in r/r cll patients
-
1:22
the importance of venetoclax in treating cll
-
6:17
the progression and evolution of cll: mechanisms and therapies
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
1:01
cll resistance mechanisms in the era of novel agents
-
1:19
cll treatment: a look into the future
-
1:21
treating cll with venetoclax
-
3:33
investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
-
1:39
the growing role of mrd as a clinical endpoint in cll
-
1:23
the cll epigenome
-
2:12
complete epigenome of cll reveals important areas of dysregulation